To date, more than 200 monogenic, often devastating, skin diseases have been described. Because of unmet medical needs, development of long-lasting and curative therapies has been consistently attempted, with the aim of correcting the underlying molecular defect. In this review, we will specifically address the few combined cell and gene therapy strategies that made it to the clinics. Based on these studies, what can be envisioned for the future is a patient-oriented strategy, built on the specific features of the individual in need. Most likely, a combination of different strategies, approaches, and advanced therapies will be required to reach the finish line at the end of the long and winding road hampering the achievement of definitive treatments for genodermatoses.
Cellule staminali e medicina rigenerativa
L’integrità e la riparazione dei tessuti dipendono da una popolazione di cellule staminali adulte presente nei tessuti stessi e in grado di autorinnovarsi. La Medicina Rigenerativa si occupa dello sviluppo di terapie avanzate mirate alla ricostruzione di tessuti e organi irrimediabilmente danneggiati.